Atossa Therapeutics
ATOS
#10636
Rank
NZ$44.73 M
Marketcap
NZ$4.48
Share price
1.52%
Change (1 day)
244.99%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -NZ$64.37 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$58.16 Million a decrease over its 2024 earnings that were of -NZ$42.66 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$64.37 Million10.68%
2025 -NZ$58.16 Million36.33%
2024 -NZ$42.66 Million-15.25%
2023 -NZ$50.34 Million11.62%
2022 -NZ$45.1 Million30.84%
2021 -NZ$34.47 Million15.58%
2020 -NZ$29.82 Million3.41%
2019 -NZ$28.84 Million51.16%
2018 -NZ$19.08 Million40.41%
2017 -NZ$13.59 Million27.54%
2016 -NZ$10.66 Million-47.49%
2015 -NZ$20.29 Million-17.25%
2014 -NZ$24.52 Million35.91%
2013 -NZ$18.04 Million112.3%
2012 -NZ$8.5 Million46.53%
2011 -NZ$5.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$43.45 B-69,117.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$2.30 B-3,755.59%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$2.30 B-3,753.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
NZ$69.71 M-210.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-NZ$0.17 Billion 164.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-NZ$13.12 Million-79.17%๐Ÿ‡บ๐Ÿ‡ธ USA